FCA Corp’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-23,272
| Closed | -$1.37M | – | 184 |
|
|
2024
Q2 | $1.37M | Buy |
23,272
+812
| +4% | +$50.8K | 0.44% | 70 |
|
|
2024
Q1 | $1.79M | Buy |
22,460
+335
| +2% | +$25.6K | 0.58% | 57 |
|
|
2023
Q4 | $1.75M | Sell |
22,125
-23
| -0.1% | -$1.64K | 0.6% | 56 |
|
|
2023
Q3 | $1.55M | Buy |
22,148
+504
| +2% | +$35.7K | 0.58% | 57 |
|
|
2023
Q2 | $1.5M | Buy |
21,644
+244
| +1% | +$17.4K | 0.55% | 61 |
|
|
2023
Q1 | $1.59M | Buy |
21,400
+638
| +3% | +$53.5K | 0.6% | 56 |
|
|
2022
Q4 | $1.93M | Buy |
20,762
+330
| +2% | +$31.8K | 0.78% | 50 |
|
|
2022
Q3 | $1.95M | Buy |
20,432
+127
| +0.6% | +$12.6K | 0.83% | 46 |
|
|
2022
Q2 | $1.88M | Buy |
20,305
+196
| +1% | +$19.1K | 0.74% | 50 |
|
|
2022
Q1 | $2.04M | Buy |
20,109
+122
| +0.6% | +$12.8K | 0.71% | 50 |
|
|
2021
Q4 | $2.06M | Sell |
19,987
-1,922
| -9% | -$178K | 0.7% | 48 |
|
|
2021
Q3 | $1.86M | Buy |
21,909
+220
| +1% | +$18.4K | 0.56% | 65 |
|
|
2021
Q2 | $1.81M | Buy |
21,689
+144
| +0.7% | +$11.8K | 0.51% | 67 |
|
|
2021
Q1 | $1.62M | Sell |
21,545
-100
| -0.5% | -$7.28K | 0.47% | 72 |
|
|
2020
Q4 | $1.48M | Buy |
21,645
+136
| +0.6% | +$8.85K | 0.47% | 72 |
|
|
2020
Q3 | $1.26M | Buy |
21,509
+55
| +0.3% | +$3.42K | 0.43% | 72 |
|
|
2020
Q2 | $1.39M | Sell |
21,454
-109
| -0.5% | -$6.86K | 0.53% | 63 |
|
|
2020
Q1 | $1.28M | Sell |
21,563
-169
| -0.8% | -$11.3K | 0.56% | 61 |
|
|
2019
Q4 | $1.61M | Sell |
21,732
-4
| -0% | -$281 | 0.56% | 67 |
|
|
2019
Q3 | $1.37M | Sell |
21,736
-221
| -1% | -$13.1K | 0.51% | 71 |
|
|
2019
Q2 | $1.2M | Sell |
21,957
-46
| -0.2% | -$2.48K | 0.44% | 77 |
|
|
2019
Q1 | $1.19M | Buy |
22,003
+3,000
| +16% | +$185K | 0.46% | 74 |
|
|
2018
Q4 | $1.25M | Buy |
19,003
+9,452
| +99% | +$706K | 0.56% | 63 |
|
|
2018
Q3 | $752K | Sell |
9,551
-4,892
| -34% | -$350K | 0.29% | 83 |
|
|
2018
Q2 | $929K | Sell |
14,443
-730
| -5% | -$48.1K | 0.37% | 75 |
|
|
2018
Q1 | $944K | Sell |
15,173
-255
| -2% | -$18.3K | 0.39% | 73 |
|
|
2017
Q4 | $1.12M | Sell |
15,428
-565
| -4% | -$41.1K | 0.45% | 68 |
|
|
2017
Q3 | $1.3M | Buy |
15,993
+354
| +2% | +$28K | 0.54% | 68 |
|
|
2017
Q2 | $1.26M | Buy |
15,639
+473
| +3% | +$37.3K | 0.55% | 65 |
|
|
2017
Q1 | $1.19M | Buy |
15,166
+9,444
| +165% | +$754K | 0.56% | 62 |
|
|
2016
Q4 | $452K | Sell |
5,722
-6,317
| -52% | -$511K | 0.22% | 73 |
|
|
2016
Q3 | $1.07M | Buy |
+12,039
| New | +$1.14M | 0.55% | 62 |
|
Other funds holding CVS
FCA Corp's CVS Position: Q3 2024 in Review
FCA Corp sold out of CVS Health (CVS) in Q3 2024, closing a stake of 23,272 shares — an estimated $1.37M sold.
FCA Corp first reported a position in CVS in Q3 2016 and held it in 32 quarters. The position peaked at $2.06M in Q4 2021. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- FCA Corp reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
- FCA Corp sold 23,272 CVS Health shares in Q3 2024, an estimated $1.37M.
- FCA Corp first reported a position in CVS Health in Q3 2016 and held it in 32 quarters.
- FCA Corp's CVS Health position peaked at $2.06M in Q4 2021.
- 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on FCA Corp's 13F filing for Q3 2024, filed 13 Nov 2024.